UK biopharma company Circassia has raised £60 million funding for the final stage of development of its anti-allergy products. The …
A number of late stage failures from British biotech firms have left a looming question mark over the future of …
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions

